YEWTF yields 2631.58% · PFE yields 6.13%● Live data
📍 YEWTF pulled ahead of the other in Year 1
Combined, YEWTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YEWTF + PFE for your $10,000?
Environmental Waste International Inc., together with its subsidiaries, designs and develops environmental products for waste treatment and disposal in Canada and the United States. It researches, designs, develops, sells, and maintains systems based on the patented Reverse Polymerization process and related delivery system. The company provides systems for feed tire reduction, biological wastewater sterilization, shipboard food waste sterilization/dehydration, and batch-based infectious medical waste sterilization. Its tire system breaks the molecular bonds in tires and other rubber products and reduces them to their base components of carbon black, steel, and hydrocarbon vapors. The company also offers FS-6000 and FS-POD biocontainment and wastewater sterilization units; MD-1000, a three-stage, three chamber, medical waste reduction unit that produces a sterilized carbon residue; and AW-1000 to process and reduce animal waste into its constituents. Environmental Waste International Inc. was incorporated in 1987 and is headquartered in Whitby, Canada.
Full YEWTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.